₹377.40-2.70 (-0.71%)
13-Dec-2024₹377.40-3.20 (-0.84%)
13-Dec-2024BSE : 540025
NSE : ADVENZYMES
Sector : Health care
ISIN Code : INE837H01020
Last Updated: 13-Dec-2024
Market Cap (₹ Cr) | 4,223 |
Traded Value (₹ Cr) | 0.26 |
Volume (Shares) | 6,910 |
Face Value (₹) | 2 |
52-Week High (₹) | 571.15 |
52-Week High Date | 16-Sep-2024 |
52-Week Low (₹) | 334.05 |
52-Week Low Date | 05-Jun-2024 |
All Time High (₹) | 571.15 |
All Time High Date | 16-Sep-2024 |
All Time Low (₹) | 91.05 |
All Time Low Date | 23-Mar-2020 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 4,223 |
EPS - TTM (₹) [C] | 13.16 |
P/E Ratio (X) [C] | 28.68 |
Face Value (₹) | 2 |
Latest Dividend (%) | 55.00 |
Latest Dividend Date | 18-Jul-2024 |
Dividend Yield (%) | 1.35 |
Book Value Share (₹) [C] | 119.92 |
P/B Ratio (₹) [C] | 3.15 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
HDFC Small Cap Fund (G) | 108.43 | 28,67,468 | 0.32 |
HDFC Small Cap Fund (IDCW) | 108.43 | 28,67,468 | 0.32 |
HDFC Small Cap Fund - Direct (G) | 108.43 | 28,67,468 | 0.32 |
HDFC Small Cap Fund - Direct (IDCW) | 108.43 | 28,67,468 | 0.32 |
UTI-MNC Fund (G) | 37.82 | 10,00,000 | 1.27 |
UTI-MNC Fund (IDCW) | 37.82 | 10,00,000 | 1.27 |
UTI-MNC Fund - Direct (G) | 37.82 | 10,00,000 | 1.27 |
UTI-MNC Fund - Direct (IDCW) | 37.82 | 10,00,000 | 1.27 |
ICICI Pru ESG Exclusionary Strategy Fund-Reg (G) | 32.98 | 8,72,022 | 2.16 |
ICICI Pru ESG Exclusionary Strategy Fund-Reg (IDCW) | 32.98 | 8,72,022 | 2.16 |
Load more
Date | Broker | Action | Prices(₹) | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High (₹) | 374.00 381.15 |
Week Low/High (₹) | 374.00 411.00 |
Month Low/High (₹) | 365.40 411.00 |
Year Low/High (₹) | 334.05 571.00 |
All time Low/High (₹) | 91.05 571.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 0.12% | 0.23% | 0.52 | 0.37% |
1 Month | -0.30% | -0.04% | 5.72 | 5.13% |
3 Month | -29.33% | -29.23% | -0.91 | -2.32% |
6 Month | -1.24% | -1.15% | 6.93 | 5.85% |
1 Year | 3.07% | 3.13% | 18.03 | 18.36% |
3 Year | 7.84% | 7.69% | 40.92 | 42.61% |
Whole-time director : MUKUND MADHUSUDAN KABRA
Chairman (Non-Executive) : VASANT RATHI
Independent Director : Pramod Kasat
Company Sec. & Compli. Officer : Sanjay Basantani
Non-Exec & Non-Independent Dir : Rasika Rathi
Independent Director : Vindokumar Hiralal Jajoo
Non-Exec & Non-Independent Dir : Sunny Sharma
Independent Director : Rajshree Patel
Independent Director : NITIN JAGANNATH DESHMUKH
Independent Director : Vandana Tilak.
Registered Office: Sun Magnetica 5th Floor, Nr LIC Serivce Road Louiswadi,Thane,Maharashtra-400604 Ph: 91-22-41703200
1. What's the Advanced Enzyme Technologies Ltd share price today?
Advanced Enzyme Technologies Ltd share price was Rs 377.40 at close on 13th Dec 2024. Advanced Enzyme Technologies Ltd share price was down by 0.71% from the previous closing price of Rs 380.10. Advanced Enzyme Technologies Ltd share price trend:
2. How can I quickly analyse the performance of the Advanced Enzyme Technologies Ltd stock?
The performance of the Advanced Enzyme Technologies Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Advanced Enzyme Technologies Ltd?
Advanced Enzyme Technologies Ltd has a market capitalisation of Rs 4,223 crore.
4. What is Advanced Enzyme Technologies Ltd's 52-week high/low share price?
The Advanced Enzyme Technologies Ltd’s 52-week high share price is Rs 571.15 and 52-week low share price is Rs 334.05.
5. Is the Advanced Enzyme Technologies Ltd profitable?
On a consolidated basis, Advanced Enzyme Technologies Ltd reported a profit of Rs 9.13 crore on a total income of Rs 79.04 crore for the quarter ended 2024. For the year ended Sep 2024, Advanced Enzyme Technologies Ltd had posted a profit of Rs 33.39 crore on a total income of Rs 155.71 crore.
6. Which are Advanced Enzyme Technologies Ltd’s peers in the Health care sector?
Advanced Enzyme Technologies Ltd’s top 5 peers in the Health care sector are Sequent Scien., Dishman Carbogen, Gufic BioScience, Advanced Enzyme, Aarti Drugs, RPG LifeScience., Guj. Themis Bio..
7. Who owns how much in Advanced Enzyme Technologies Ltd?
Key changes to the Advanced Enzyme Technologies Ltd shareholding are as follows: